A review of the manufacturing records for the device could not be conducted because the serial/lot number remains unknown.Additional information was requested but was not available.The device remains implanted and is not available for analysis.It was reported by the physician that the endoleak at the left side was not observed.However, just to be saved, the physician decided to implant additional stent grafts to extend distally at the left side.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), the physician and patient should review the risks and benefits when discussing this endovascular device and procedure including: the possibility that subsequent interventional or open surgical repair of the aneurysm may be required after initial endovascular repair.The final treatment decision is at the discretion of the physician and patient.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
On (b)(6) 2016, a patient underwent an endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.A trunk ipsilateral leg component (rlt231416/unknown) was implanted to a right side.A contralateral leg component (plc141400/unknown) was implanted to a left side.On (b)(6) 2022, a reintervention was performed as a preventive action at the left side.A distal type i endoleak at the left side was not observed.However, just to be saved, the physician decided to implant an additional stent graft to extend distally at the left side.Additionally, a stent graft was implanted to extend to a branch of the left internal and the external iliac arteries.The patient tolerated the procedure.
|